For Gaucher Disease, a rare disease, which requires high-value medication for treatment, Shanghai has established a multi-tiered system consisting of the Basic Medical Insurance (BMI), the Shanghai Rare Disease Prevention and Control Foundation Lysosomal Storage Disease Special Aid Fund (SAF), and the Shanghai Primary and Secondary School Students, Infants and Children Hospitalization Medical Mutual Fund (CHMF) for insuring Gaucher Disease. This security system was the leading one in China at that time, and patients with Gaucher Disease in Shanghai could really have access to medicine. In order to understand the guarantee of high-value specific drugs for Gaucher Disease patients, this paper analyzed the cost-sharing situation of Gaucher Disease from 2018 to 2020, and found that the total cost for six patients was 36.35 millions Chinese Yuan (CNH), an average of 2.02 millions CNH for per person per year. Among the costs, the proportions of BMI, SAF and individual out-of-pocket rate were 79.02%, 16.28% and 4.70%, respectively. From the Shanghai coverage experience, it can be found that high-value drugs for rare diseases are very expensive, a high level of coverage is needed to ensure that patients actually have access to the drugs, and this often requires multiple parties to work together to establish a coverage mechanism.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |